You are viewing an incomplete version of our website. Please click to reload the website as full version.

Actin-Like 7b (Actl7b) (AA 68-97), (N-Term) anticorps

Détails pour le produit réf. ABIN950264, Fournisseur: Connectez-vous pour afficher Nouveau
Request Données supplémentaires souhaité pour un produit?

L'Initiative de validation indépendante s'efforce de vous fournir des données de haute qualité. Savoir plus

Synonymes ACTL7B, Tact1
N-Term, AA 68-97
(27), (15), (15), (15), (10), (7), (7), (4), (4), (2), (2), (1), (1), (1)
(58), (36), (11), (2)
(51), (33), (9)
(6), (6), (6), (6), (6), (6)
Enzyme Immunoassay (EIA), Western Blotting (WB)
(88), (59), (7), (3)
Pubmed 4 références disponible
Fournisseur Connectez-vous pour afficher Nouveau
Numéro du produit fournisseur Connectez-vous pour afficher Nouveau
Quantité 0.4 mL
Destination France ( )
Disponibilité Envoi sous 8 à 10 jours ouvrables
Immunogène KLH conjugated synthetic peptide between 68-97 amino acids from the N-terminal region of human ACTL7B
Isotype Ig
Specificité This antibody reacts to ACTL7B.
Réactivité croisée (Details) Species reactivity (tested):Human.
Purification Affinity chromatography on Protein A
Autre désignation ACTL7B (Actl7b Antibody Extrait)
Sujet The protein encoded by this gene is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. This gene (ACTL7B), and related gene, ACTL7A, are intronless, and are located approximately 4 kb apart in a head-to-head orientation within the familial dysautonomia candidate region on 9q31. Based on mutational analysis of the ACTL7B gene in patients with this disorder, it was concluded that it is unlikely to be involved in the pathogenesis of dysautonomia. Unlike ACTL7A, the ACTL7B gene is expressed predominantly in the testis, however, its exact function is not known.Synonyms: Actin-like protein 7B, Actin-like-7-beta
ID gène 10880
NCBI Accession NP_006677
Domaine de recherche Signaling, Cytoskeleton, Microfilaments
Indications d'application Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS containing 0.09 % (W/V) sodium azide as preservative
Agent conservateur Sodium azide
Précaution d'utilisation This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation Avoid repeated freezing and thawing.
Stock 4 °C/-20 °C
Stockage commentaire Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Supplier Images
Western Blotting (WB) image for anti-Actin-Like 7b (Actl7b) (AA 68-97), (N-Term) anticorps (ABIN950264) ACTL7B Antibody (N-term) western blot analysis in NCI-H292 cell line lysates (35µg/la...
Reference: Background Humphray, Oliver, Hunt et al.: "DNA sequence and analysis of human chromosome 9. ..." dans: Nature, Vol. 429, Issue 6990, pp. 369-74, 2004 (PubMed).

Hisano, Ohta, Nishimune et al.: "Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells." dans: Nucleic acids research, Vol. 31, Issue 16, pp. 4797-804, 2003 (PubMed).

Klionsky, Ohsumi: "Vacuolar import of proteins and organelles from the cytoplasm." dans: Annual review of cell and developmental biology, Vol. 15, pp. 1-32, 2000 (PubMed).

Chadwick, Mull, Helbling et al.: "Cloning, mapping, and expression of two novel actin genes, actin-like-7A (ACTL7A) and actin-like-7B (ACTL7B), from the familial dysautonomia candidate region on 9q31." dans: Genomics, Vol. 58, Issue 3, pp. 302-9, 1999 (PubMed).

N° du produit ABIN950264
418,00 €
Plus frais de livraison 40,00 € et TVA

Contact commande:

  • +33 (0)1 76 63 32 65
  • +33 (0)1 74 18 08 22